A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased Effect of CNS depressant when combined with opioid agonists
may have an increased effect of a CNS depressant when combined with cannabinoid products
may have an increased effect of a CNS depressant when combined with cannabinoid products
CNS Depressants: they may increase the CNS depressant effect of antihistamines
CNS Depressants: they may increase the CNS depressant effect of antihistamines
CNS Depressants: they may increase the CNS depressant effect of antihistamines
CNS Depressants: they may increase the CNS depressant effect of antihistamines
CNS Depressants: they may increase the CNS depressant effect of antihistamines
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
may increase the CNS depressant of opioid agonists
may have an increased CNS depressant effect when combined with flunitrazepam
may have an increased CNS depressant effect when combined with flunitrazepam
may have an increased CNS depressive effect when combined with suvorexant
may have an increased CNS depressant effect when combined with buprenorphine
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with zolpidem
may have an increased CNS depressant effect when combined with dexmedetomidine
may have an increased Effect of a CNS depressant when combined with oxycodone
dexmedetomidine: they may increase the CNS depressant effect of CNS Depressants
ropeginterferon alfa 2b: they may increase the CNS depressant effect of CNS Depressants
obinutuzumab: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
guanethidine: they may increase the CNS depressant effect of CNS Depressants
potassium phosphate: they may increase the CNS depressant effect of CNS Depressants
nitroglycerin: they may increase the CNS depressant effect of CNS Depressants
cocaine: they may increase the CNS depressant effect of CNS Depressants
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
it increases the effect of CNS depressants
it increases the efficacy of CNS depressants
may have an increased CNS depressant effect when combined with flunarizine
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
CNS depressants increase the efficacy of thalidomide
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with orphenadrine
may have an increased CNS depressant effect when combined with paraldehyde
bromperidol: they may increase the CNS depressant effect of CNS Depressants
revefenacin: they may increase the CNS depressant effect of CNS Depressants
betahistine: they may increase the CNS depressant effect of CNS Depressants
doxofylline: they may increase the CNS depressant effect of CNS Depressants
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the risk of adverse/toxic effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
could increase the vasopressor action
may have an increased CNS depressant effect when combined with alcohol
When clorazepic acid is used together with norelgestromin, this leads to a rise in norelgestromin’s metabolism
When clorazepic acid is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
When acepromazine is used together with clorazepic acid, this leads to enhanced risk or seriousness of CNS depression
may have an increased CNS depressant effect when combined with alcohol
may have an increasingly adverse effect when combined with sodium phosphates
may have an increasingly adverse effect when combined with sodium phosphates
may have an increasingly adverse effect when combined with sodium phosphates
may have an increasingly adverse effect when combined with sodium phosphates
may have an increasingly adverse effect when combined with sodium phosphates
The interaction may enhance the drug serum levels of benzodiazepine agonist hypnotics
The interaction may enhance the drug serum levels of benzodiazepine agonist hypnotics
The interaction may enhance the drug serum levels of benzodiazepine agonist hypnotics
CNS Depressants may enhance the CNS depressant effect of brexanolone
mefloquine may diminish the therapeutic effect of antiseizure agents
it increases the effect of CNS depressants
it decreases the concentration of antiseizure agents in the serum
CNS depressants increase the effect of sedation of pramipexole
may increase the CNS depressant effect
may increase the CNS depressant effect
may have an increased CNS depressive effect of CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
they increase the toxicity of other CNS depressants
it increases the toxicity of CNS depressants
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with cannabinoid-containing products
may have an increased CNS depressant effect when combined with cannabinoid-containing products
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may increase the toxic effect of CNS depressants
may increase the toxic effect of CNS depressants
may increase the toxic effect of antipsychotics
may have an increased CNS depressant effect when combined with brexanolone
metoclopramide: they may increase the CNS depressant effect of CNS Depressants
minocycline (Systemic): they may increase the CNS depressant effect of CNS Depressants
may increase the toxic effect of CNS Depressants
may increase the serotonergic effects
they increase the effect of sedation of ropinirole
metyrosine: they may increase the sedative effect of CNS Depressants
may increase the toxic effect of Seizure Threshold, Lowering Potential agents
The sedative effect of rotigotine might be intensified by the presence of CNS Depressants
perampanel: they may increase the CNS depressant effect of CNS Depressants
ozanimod: they may increase the CNS depressant effect of CNS Depressants
seizure lowering agents increase the toxic or adverse effects of iomeprol
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
valerian: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
lutropin alfa: they may increase the CNS depressant effect of CNS Depressants
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
aminolevulinic acid: they may increase the CNS depressant effect of CNS Depressants
sparsentan: they may increase the CNS depressant effect of CNS Depressants
indoramin: they may increase the CNS depressant effect of CNS Depressants
lithium: they may increase the CNS depressant effect of CNS Depressants
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
aldesleukin: it may decrease the excretion rate of abacavir CNS depressant
acetazolamide: it may increase the risk or severity of CNS depression
aceclofenac: it may increase the risk or severity of CNS depression
acebutolol: it may increase the risk or severity of CNS depression
balsalazide: it may increase the risk or severity of CNS depression
mepyramine: it may increase the risk or severity of CNS depression
acrivastine: it may increase the risk or severity of CNS depression
alfentanil: it may increase the risk or severity of CNS depression
baricitinib: it may increase the risk or severity of CNS depression
baclofen: it may increase the risk or severity of CNS depression
carbidopa: it may increase the risk or severity of CNS depression
dabrafenib: it may increase the risk or severity of CNS depression
dapagliflozin: it may increase the risk or severity of CNS depression
amantadine: it may increase the risk or severity of CNS depression
benzphetamine: it may increase the risk or severity of CNS depression
anagrelide: it may increase the risk or severity of CNS depression
benzyl alcohol: it may increase the risk or severity of CNS depression
mianserin: it may increase the risk or severity of CNS depression
anakinra: it may decreased the serum concentration of CNS depressants
bortezomib: it may increase the metabolism of CNS depressants
brivaracetam: it may increase the metabolism of CNS depressants
carvedilol: it may increase the metabolism of CNS depressants
may increase the CNS depressant effect of CNS depressants
clorazepic acid might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
CNS depressants increase the effect of zolpidem
it increases the effect of CNS depressants
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
